LRP5 and head and neck cancer: Taken together, these results suggest that overexpression of UBE3C-LRP5 fusion, but not LRP5, is sufficient to induce tumorigenesis in vitro and in vivo and promote migration and invasion of head and neck cancer cells in vitro.